oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Gram-Negative Bacterial Infections D016905 16 associated lipids
Uterine Cervical Diseases D002577 2 associated lipids
Peptic Ulcer D010437 19 associated lipids
Dermatitis D003872 30 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Hypertension, Renal D006977 9 associated lipids
Foot Diseases D005534 4 associated lipids
Enteritis D004751 8 associated lipids
Pasteurella Infections D010326 8 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
MAGILL GB and KILLOUGH JH Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis. 1953 AMA Arch Intern Med pmid:13016039
SNYDER W Terramycin therapy of eczema vaccinatum; report of a case. 1951 AMA Arch Derm Syphilol pmid:14867923
NIEDELMAN ML Molluscum contagiosum treated with oxytetracycline (terramycin). 1953 AMA Arch Derm Syphilol pmid:13007184
MOPPER C Terramycin therapy of molluscum contagiosum. 1952 AMA Arch Derm Syphilol pmid:14914183
TSCHAN DN and WRIGHT CS Safety of systemic oxytetracycline (terramycin) therapy following or with topical therapy. 1954 AMA Arch Derm Syphilol pmid:13147576
ZELIGMAN I and SINESI SJ Carbuncle caused by Gaffkya tetragena treated with oxytetracycline (terramycin). 1953 AMA Arch Derm Syphilol pmid:13091374
WRIGHT CS and TSCHAN DN Local oxytetracycline (terramycin) therapy of skin infections. 1953 AMA Arch Derm Syphilol pmid:13029894
BALER GR Oxytetracycline intramuscular in the treatment of early syphilis. 1956 AMA Arch Derm pmid:13312644
BAREFOOT SW Oxytetracycline hydrochloride-polymyxin B sulfate topical powder. 1959 AMA Arch Derm pmid:13636430
STRITZLER C and FRANK L Topical hydrocortisone-oxytetracycline therapy. 1955 AMA Arch Derm pmid:14375396
BUMBALO TS et al. Pinworm infection (enterobiasis) in children; a comparative study of four oxyuricides. 1953 AMA Am J Dis Child pmid:13103773
Malatinszky I Two possibilities of further reduction in mortality from tuberculosis. 1967 Am. Rev. Respir. Dis. pmid:6018714
Ashegyi B and Malatinszky I Bronchial pulmonary disease associated with tuberculous lymph nodes. 1968 Am. Rev. Respir. Dis. pmid:5647212
Ayvazian LF et al. Erythrokinetic studies during antimicrobial therapy in pulmonary emphysema. 1969 Am. Rev. Respir. Dis. pmid:5810804
Albert WC and Inkley SR The efficacy of steroid therapy in the treatment of experimental kerosene pneumonitis. 1968 Am. Rev. Respir. Dis. pmid:5683485
CONN HO et al. ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE. 1964 Am. Rev. Respir. Dis. pmid:14221666
PHILLIPS S RELAPSE IN TREATED CASES OF PULMONARY TUBERCULOSIS. I. THREE-YEAR FOLLOW-UP OF 312 PATIENTS DISCHARGED FROM THE HOSPITAL WITH MEDICAL APPROVAL, 1947-1954. 1964 Am. Rev. Respir. Dis. pmid:14178617
Roby TO et al. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline. 1978 Am. J. Vet. Res. pmid:677530
Teare JA et al. Pharmacokinetics of a long-acting oxytetracycline preparation in ring-necked pheasants, great horned owls, and Amazon parrots. 1985 Am. J. Vet. Res. pmid:4083606
Nicoletti P et al. Efficacy of various treatment regimens, using liposomal streptomycin in cows with brucellosis. 1989 Am. J. Vet. Res. pmid:2505648
Toutain PL and Raynaud JP Pharmacokinetics of oxytetracycline in young cattle: comparison of conventional vs long-acting formulations. 1983 Am. J. Vet. Res. pmid:6881660
Ames TR et al. Oxytetracycline concentrations in healthy and diseased calves. 1983 Am. J. Vet. Res. pmid:6881673
Latour PB and Barnum DA Use of ducks as a model to study the effect of antibiotics in feed on the fecal shedding of Salmonella. 1981 Am. J. Vet. Res. pmid:7041704
Kniffen TS et al. Bioavailability, pharmacokinetics, and plasma concentration of tetracycline hydrochloride fed to swine. 1989 Am. J. Vet. Res. pmid:2712418
Varma KJ and Paul BS Pharmacokinetics and plasma protein binding (in vitro) of oxytetracycline in buffalo (Bubalus bubalis). 1983 Am. J. Vet. Res. pmid:6838044
Dyer DC Pharmacokinetics of oxytetracycline in the turkey: evaluation of biliary and urinary excretion. 1989 Am. J. Vet. Res. pmid:2712419
Marín CM et al. Efficacy of long-acting oxytetracycline alone or in combination with streptomycin for treatment of Brucella ovis infection of rams. 1989 Am. J. Vet. Res. pmid:2712423
Davis RW et al. The effects of an oxytetracycline preparation on the thyroid gland: a preliminary report. 1966 Am. J. Vet. Res. pmid:5913021
Owen RA et al. Effects of transportation, surgery, and antibiotic therapy in ponies infected with Salmonella. 1983 Am. J. Vet. Res. pmid:6337537
Kerwin SC et al. Effect of hyperbaric oxygen treatment on incorporation of an autogenous cancellous bone graft in a nonunion diaphyseal ulnar defect in cats. 2000 Am. J. Vet. Res. pmid:10850847
Toofanian F and Targowski S Experimental production of rabbit mucoid enteritis. 1983 Am. J. Vet. Res. pmid:6346966
Ferré PJ et al. Comparison of ultrasonography and pharmacokinetic analysis of creatine kinase release for quantitative assessment of postinjection muscle damage in sheep. 2001 Am. J. Vet. Res. pmid:11703010
Brown MP and MacCallum FJ A system of grading ossification in limbs of foals to assist in radiologic interpretation. 1975 Am. J. Vet. Res. pmid:1137212
Kaneene JB et al. Drug residues in milk after intrauterine injection of oxytetracycline, lincomycin-spectinomycin, and povidone-iodine in cows with metritis. 1986 Am. J. Vet. Res. pmid:2942064
MacNeil JD et al. Bioassay techniques and high-performance liquid chromatography for detection of oxytetracycline residues in tissues from calves. 1989 Am. J. Vet. Res. pmid:2919831
Bretzlaff KN et al. Distribution of oxytetracycline in the genital tract of cows. 1982 Am. J. Vet. Res. pmid:7091807
Lincoln SD et al. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period. 1982 Am. J. Vet. Res. pmid:7103219
Lubbers BV et al. Effects of two simulated oxytetracycline dosing regimens on horizontal transfer of antimicrobial resistance plasmids in an in vitro pharmacodynamic model. 2011 Am. J. Vet. Res. pmid:21728847
Kuttler KL Efficacy of oxytetracycline and a dithiosemicarbazone in the treatment of bovine anaplasmosis. 1971 Am. J. Vet. Res. pmid:5094519
Riner JL et al. Influence of density and location on degradation of sustained-release boluses given to cattle. 1982 Am. J. Vet. Res. pmid:7181203
Hatch RC et al. Effect of antibacterials, anabolic steroid, and diethyldithiocarbamate on induced acute aflatoxicosis in goats. 1982 Am. J. Vet. Res. pmid:6280533
Gross DR et al. Cardiovascular effects of intravenous administration of propylene glycol and of oxytetracycline in propylene glycol in calves. 1979 Am. J. Vet. Res. pmid:475130
McElroy DE et al. Pharmacokinetics of oxytetracycline hydrochloride in rabbits. 1987 Am. J. Vet. Res. pmid:3631718
Anderson KL et al. Potential for oxytetracycline administration by three routes to cause milk residues in lactating cows, as detected by radioimmunoassay (Charm II) and high-performance liquid chromatography test methods. 1995 Am. J. Vet. Res. pmid:7695153
Moats WA et al. Comparison of a radioimmunoassay (Charm II) test with high-performance liquid chromatography for detection of oxytetracycline residues in milk samples from lactating cattle. 1995 Am. J. Vet. Res. pmid:7653890
Simpson CF Morphologic alteration of Paranaplasma caudata following treatment of calves with oxytetracycline. 1977 Am. J. Vet. Res. pmid:931133
Paulsen DB et al. Use of an indwelling bronchial catheter model of bovine pneumonic pasteurellosis for evaluation of therapeutic efficacy of various compounds. 1992 Am. J. Vet. Res. pmid:1524292
Smith JA and George LW Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation. 1985 Am. J. Vet. Res. pmid:4014830
Fecteau KA and Eiler H Evaluation of injections of collagenase and oxytetracycline via the umbilical artery as treatment for retained placenta in cattle. 1996 Am. J. Vet. Res. pmid:8712518
Myers MJ et al. In vitro modulation of bovine blood neutrophils and mononuclear cells by oxytetracycline. 1995 Am. J. Vet. Res. pmid:8533970